Sales Growth YoY (Last Twelve Months): Structure Corp (GPCR)

Graphic logo of Structure Therapeutics (GPCR)

Structure Therapeutics is implementing computational design to replace injections with pills. The year-over-year percentage change in LTM sales volume visualizes this progress, where the value of 0.00 characterizes this level. Success is based on transparent R&D management and the attraction of investment. Stability is ensured by hiring top endocrinologists and an effective stock option system to retain scientists.

Sales Growth YoY (Last Twelve Months): Structure Pharma (GPCR) for 02/11/2024 - 11/15/2026

Summary analytical data breakdowns for Structure Therapeutics Inc (GPCR)

- market value and analyst target forecast:
- company stock exchange capitalization indicators:
Fundamental company valuation:Structure Corp GPCR
Mass-produced product of Structure Therapeutics Inc.

This indicator measures revenue dynamics over a rolling twelve-month period relative to the same period last year, allowing for an assessment of business scaling rates. By analyzing the trend of sales changes year-over-year over a 12-month period, an investor can compare the financial stability of Structure Therapeutics (GPCR) with its progress in developing an oral GLP-1, where the absence of commercial sales renders this metric secondary to clinical trial results.

Competitors of Structure Therapeutics (GPCR)

Ascendis (ASND) - Trailing Twelve Months Revenue Growth|MDGL - Sales Growth YoY (Last Twelve Months)|CORT: Sales Growth YoY (Last Twelve Months)|RYTM: Sales Growth YoY (TTM)|AKRO - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Metsera Therapeutics|MoonLake Corp (MLTX) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) crinetics.com (CRNX)|Revenue Growth YoY (Last 12 Months) newamsterdampharma.com NAMS|Sales Growth YoY (Last Twelve Months) Soleno Therapeutics Inc SLNO|Sales Growth YoY (TTM) Amicus Therapeutics Inc FOLD|89bio Corp - Sales Growth YoY (TTM)|Revenue Growth Rate YoY (Last Twelve Months) Agios Pharmaceuticals Inc (AGIO)|mimedx.com (MDXG) - Sales Growth YoY (Last Twelve Months)|Trailing Twelve Months Sales Growth RZLT (rezolutebio.com)|LXRX (Lexicon Pharmaceuticals Inc) - Sales Growth YoY (TTM)|Sales Growth YoY (Last Twelve Months) MBX|Sales Growth YoY (Last Twelve Months) Altimmune Pharma (ALT)|Sales Growth YoY (Last Twelve Months) AARD (Aardvark Therapeutics Corp)|Sales Growth YoY (TTM) SGMT (Sagimet Biosciences, Inc.)|BioAge (BIOA) - Trailing Twelve Months Revenue Growth|BMEA: Revenue Growth YoY (Last 12 Months)|Revenue Dynamics YoY (Last Twelve Months) QNCX (Quince Therapeutics Inc)|GUTS (Fractyl) - Revenue Growth YoY (Last 12 Months)|vTv Therapeutics, Inc. - Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Agape ATP Corp.|Revenue Growth YoY (Last 12 Months) Pluri (PLUR)|Sales Growth YoY (TTM) SYBX|Annual Revenue Growth (Last Twelve Months) Lipocine Inc|Sales Growth YoY (Last Twelve Months) Matinas BioPharma Holdings MTNB|Annual Revenue Growth (Last Twelve Months) Spruce Biosciences (SPRB)|GLTO: Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Sales Growth CTCX|LUMO (Lumos Pharma) - Revenue Growth YoY (Last 12 Months)|Sales Growth YoY (Last 12 Months) ONVO|RDUS (Radius Pharmaceuticals) - Sales Growth YoY (TTM)